| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 3.644 | 22.479 | 22.775 | 69.939 |
| Total Income - EUR | - | - | - | - | - | - | 36.354 | 53.932 | 51.208 | 157.715 |
| Total Expenses - EUR | - | - | - | - | - | - | 40.479 | 58.409 | 48.312 | 65.643 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -4.126 | -4.477 | 2.896 | 92.072 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -4.126 | -4.655 | 2.668 | 90.839 |
| Employees | - | - | - | - | - | - | 2 | 3 | 1 | 2 |
Check the financial reports for the company - Herţa Bio Apicole S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 18.089 | 15.512 | 13.052 | 15.273 |
| Current Assets | - | - | - | - | - | - | 43.834 | 6.575 | 7.321 | 97.778 |
| Inventories | - | - | - | - | - | - | 9.216 | 4.965 | 3.664 | 91.346 |
| Receivables | - | - | - | - | - | - | 9.416 | 1 | 2.924 | 2.209 |
| Cash | - | - | - | - | - | - | 25.202 | 1.609 | 732 | 4.224 |
| Shareholders Funds | - | - | - | - | - | - | -4.105 | -8.774 | -6.079 | 84.794 |
| Social Capital | - | - | - | - | - | - | 20 | 20 | 20 | 20 |
| Debts | - | - | - | - | - | - | 6.193 | 2.003 | 13.400 | 17.558 |
| Income in Advance | - | - | - | - | - | - | 59.835 | 28.858 | 13.052 | 10.700 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "149 - 149" | |||||||||
| CAEN Financial Year |
149
|
|||||||||
Comments - Herţa Bio Apicole S.r.l.